Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Haemorrhage
ADR ID BADD_A05391
ADR Hierarchy
24      Vascular disorders
24.07      Vascular haemorrhagic disorders
24.07.01      Haemorrhages NEC
24.07.01.002      Haemorrhage
Description Bleeding or escape of blood from a vessel. [MeSH]
MedDRA Code 10055798
MeSH ID D006470
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Bleeding | Blood loss of (NOS) | Haemorrhage NOS | Haemorrhage symptom | Haemorrhage, unspecified | Hemorrhage | Hemorrhage (NOS) | Hemorrhage term | Hemorrhage, unspecified | Microhaemorrhage | Microhemorrhage | Secondary and recurrent haemorrhage as an early complication of trauma | Secondary and recurrent hemorrhage as an early complication of trauma | Haemorrhage NOS aggravated | Hemorrhage aggravated | Hemorrhage symptom | Haemorrhage | Uncontrolled haemorrhage | Uncontrolled hemorrhage | Acute haemorrhage | Acute hemorrhage | Major bleed | Minor bleed | Haemorrhage aggravated | Symptomatic bleeding | BARC type 3a bleeding | BARC type 0 bleeding | BARC type 1 bleeding | BARC type 3b bleeding | BARC type 3c bleeding | BARC type 4 bleeding | BARC type 2 bleeding | Moderate bleeding - GUSTO classification | Minor bleeding - TIMI classification | Minimal bleeding - TIMI classification | Mild bleeding - GUSTO classification | Severe bleeding - GUSTO classification | Requiring medical attention bleeding - TIMI classification | Major bleeding - TIMI classification | Hemorrhages
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02228Tirofiban0.005971%
BADD_D02229Tirofiban hydrochloride--
BADD_D02230Tizanidine--
BADD_D02236Tofacitinib--
BADD_D02241Tolcapone--
BADD_D02247Topiramate--
BADD_D02248Topotecan--
BADD_D02249Topotecan hydrochloride--
BADD_D02250Toremifene citrate0.000334%
BADD_D02251Torsemide--
BADD_D02252Tositumomab--
BADD_D02253Trabectedin--
BADD_D02254Tramadol--
BADD_D02257Trametinib--
BADD_D02258Trametinib dimethyl sulfoxide--
BADD_D02261Tranexamic acid0.052062%
BADD_D02268Treprostinil--
BADD_D02270Tretinoin0.001281%
BADD_D02271Triamcinolone--
BADD_D02272Triamcinolone acetonide--
BADD_D02273Triamcinolone diacetate--
BADD_D02274Triamcinolone hexacetonide--
BADD_D02287Trimethadione--
BADD_D02307Trovafloxacin--
BADD_D02308Trovafloxacin mesylate--
BADD_D02312Ulipristal0.000180%
BADD_D02319Urofollitropin--
BADD_D02320Urokinase--
BADD_D02321Ursodiol--
BADD_D02322Ustekinumab--
The 18th Page    First    Pre   18 19 20    Next   Last    Total 20 Pages
ADReCS-Target
ADR Term Drug Name Target